Experienced in Renal Cell Carcinoma (RCC)

Franck Bladou

CHU Bordeaux
Bordeaux, FR 
Experienced in Renal Cell Carcinoma (RCC)
CHU Bordeaux
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Franck Bladou practices in Bordeaux, France. Mr. Bladou is rated as an Experienced expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Nephrectomy, and Prostatectomy.

His clinical research consists of co-authoring 93 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Renal Cell Carcinoma (RCC).

Gender
Male

Locations

CHU Bordeaux
Bordeaux, France
Other Locations
Marseille, France
Talence, France
Place Amélie Raba Léon F-33000 Bordeaux, Place, 33000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 2, Multicenter, Prospective Cohort Study, Estimating the Efficacy of Focused HIFU Therapy in Patients With Localized Intermediate Risk Prostate Cancer
Phase 2, Multicenter, Prospective Cohort Study, Estimating the Efficacy of Focused HIFU Therapy in Patients With Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2025
Intervention Type: Other, Device, Procedure, Biological
Study Drug: PSA
Study Phase: Phase 2
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 22, 2025
Intervention Type: Device, Other, Procedure, Biological
Study Drug: PSA dosage
Study Phase: Phase 3
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms With Prophylactic Pentosan Polysulphate in Patients With Non-Muscle-Invasive Bladder Cancer: A Randomized Controlled Trial
Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms With Prophylactic Pentosan Polysulphate in Patients With Non-Muscle-Invasive Bladder Cancer: A Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: March 04, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

93 Total Publications

Segmental 3D image-guided robot-assisted partial nephrectomy (3D-IGRAPN) in selected cases of localized renal urothelial carcinoma.
Segmental 3D image-guided robot-assisted partial nephrectomy (3D-IGRAPN) in selected cases of localized renal urothelial carcinoma.
Journal: World journal of urology
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bladou's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile